Literature DB >> 434916

Circulating immune complexes in mucocutaneous lymph-node syndrome (Kawasaki disease)

A M Weindling, R J Levinsky, W C Marshall, J Hood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 434916      PMCID： PMC1545252          DOI： 10.1136/adc.54.3.241

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  3 in total

1.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

2.  A test for antigen--antibody complexes in human sera using IgM of rabbit antisera to human immunoglobulins.

Authors:  R J Levinsky; J F Soothill
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

3.  Mucocutaneous lymph-node syndrome (Kawasaki disease): probable soluble-complex disorder.

Authors:  C Fossard; R A Thompson
Journal:  Br Med J       Date:  1977-04-02
  3 in total
  4 in total

1.  Inhibition of lymphocyte DNA synthesis by plasma from patients with Kawasaki disease.

Authors:  J Hirao; N Izumi; Y Nagai; N Homma
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

2.  Circulating immune complex in the mucocutaneous lymph node syndrome.

Authors:  A Furuse; I Matsuda
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

3.  Complement and protease inhibitors in the mucocutaneous lymph node syndrome.

Authors:  C H Rieger; T Kawasaki; Y Yanase; U Pollack
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

Review 4.  Kawasaki Disease: The Role of Immune Complexes Revisited.

Authors:  Stephanie Menikou; Paul R Langford; Michael Levin
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.